Dense calcifications have long been viewed as one of the most challenging aspects of TLE procedures. IVL may offer specialists a new way to address that issue. 

The FDA has said this is a Class I recall, which means using the devices “may cause serious injuries or death.” A total of 18 injuries have been reported so far. 

When patients wear VR glasses during transcatheter aortic valve replacement, they say it helps time go by more quickly and reduces anxiety.

Diagnosing, treating and managing aortic stenosis is often a challenging task, especially when the patient has a long life expectancy. Shared decision-making can make a significant impact, helping ensure the patient's values and preferences are taken into consideration. 

The FDA Circulatory System Devices Panel is set to review the PMA submissions for the ReCor and Medtronic renal denervation systems to treat patients with uncontrolled hypertension.

The new-look DCB was designed to provide care with a significantly lower drug load than similar devices. 

While cardiac damage reverses in many patients following treatment, it can actually continue to get worse in others. 

The 80-year-old patient was experiencing severe TR and already had a HeartMate II LVAD.